Compliance News Roundup: OIG Senate Testimony

1. Manhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug – “Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today that TODD SCHLIFSTEIN, a doctor who practiced in Manhattan, pled guilty today to conspiracy to violate the Anti-Kickback Statute, in connection with a scheme to prescribe Subsys, a potent fentanyl-based spray, in exchange for bribes and kickbacks from Subsys’s manufacturer, Insys Therapeutics.  SCHLIFSTEIN pled guilty before U.S. Magistrate Judge Sarah Netburn. The case is assigned to U.S. District Judge Kimba M. Wood.” Get the full scoop >>

2. Encompass Health Agrees to Pay $48 Million to Resolve False Claims Act Allegations Relating to its Inpatient Rehabilitation Facilities – “This settlement demonstrates our commitment to ensuring that those who participate in federal healthcare programs follow the rules,” said Assistant Attorney General Jody Hunt for the Department of Justice’s Civil Division.  “Medicare and Medicaid providers who seek to profit inappropriately at the expense of taxpayers will be held accountable.” Get the full scoop >>

3. Deeper Than the Headlines: OIG Senate Testimony – This week we’ve got something super important and really relevant. If you’re like me, listening or reading whenever the OIG speaks or publishes something is like pure gold. It’s a good practice for any compliance officer. This includes OIG testimony given to the U.S. Congress. The latest testimony and the one I want to chat about, provided by the OIG was to the Finance Committee of the U.S. Senate. The topic was “Promoting Elder Justice: A Call for Reform” by Megan H. Tinker, Senior Advisor for Legal Affairs, Office of Counsel to the Inspector General, Office of Inspector General. Let’s dig in! Get the full scoop >>